Assessing the Efficacy of Arthrocentesis in Managing Temporomandibular Joint Disorders and Internal Derangements: A Case Series

评估关节穿刺术治疗颞下颌关节紊乱和内错位的疗效:病例系列研究

阅读:1

Abstract

Internal joint derangements (IJD) of the temporomandibular joint (TMJ) encompass a multifaceted array of conditions that have the potential to induce a gradual decline in joint health, ultimately resulting in persistent pain and disruptions in daily living. The management of these conditions poses significant hurdles to achieving effective pain management and restoration of normal TMJ functionality, presenting ongoing challenges in the medical field. At present, the approach of utilizing arthrocentesis in conjunction with intra-articular injections containing corticosteroids (CSs) and hyaluronic acid (HA) is a commonly employed method aimed at addressing chronic pain, surpassing the outcomes of more conservative treatment modalities. Nevertheless, further advancements in treatment strategies are warranted to enhance outcomes and provide holistic relief for individuals with TMJ-related concerns. The effectiveness of arthrocentesis in combination with intra-articular injections of HA and CSs has been demonstrated with the help of five case reports of elderly patients with IJD. All were chronic patients who were unresponsive to conservative management and presented with chronic pain and reduced mouth opening. Open- and closed-mouth magnetic resonance imaging (MRI) provided the diagnosis of IJD, and the patients were treated with arthrocentesis using a two-needle approach that involved flushing the joint space with Ringer's lactate solution followed by intra-articular injections of 0.5 ml HA and 0.5 ml prednisolone at a concentration of 40 mg/ml into the joint space. All patients showed a significant reduction in pain and improvement in mouth opening at the follow-up visits.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。